Revvity (RVTY) Capital Expenditures (2009 - 2026)
Revvity's (RVTY) quarterly Capital Expenditures came in at $11.1 million in Q3 2026, down 41.31% on a YoY basis from $18.9 million in Q3 2025, and down 44.01% quarter-over-quarter from $19.8 million in Q2 2026.
Analysis
Revvity (RVTY) Capital Expenditures (2009 - 2026) Analysis & Trends
Revvity (RVTY) has reported Capital Expenditures for 18 consecutive years, with $11.1 million the latest figure, recorded in Q3 2026.
- For the quarter ending Q3 2026, Capital Expenditures fell 41.31% year-over-year to $11.1 million; the trailing twelve-month figure through Jul 2026 stood at $69.5 million (down 14.83% YoY), and the FY2025 full-year result was $73.5 million, down 15.15% from the prior year.
- Capital Expenditures slipped to $11.1 million in Q3 2026 per RVTY's latest filing, from $19.8 million in the prior quarter.
- Across five years, Capital Expenditures topped out at $27.0 million in Q2 2022 and bottomed at $11.1 million in Q3 2026.
- Historically, Capital Expenditures has averaged $20.4 million across 5 years, with a median of $20.6 million in 2023.
- The sharpest annual moves came in 2022 and 2026: Capital Expenditures soared 88.45% in 2022, then slumped 41.31% in 2026.
- Over 5 years, Capital Expenditures stood at $27.0 million in 2022, then retreated by 10.58% to $24.1 million in 2023, then rose by 1.4% to $24.5 million in 2024, then dropped by 17.51% to $20.2 million in 2025, then plunged by 45.1% to $11.1 million in 2026.
- According to Business Quant data, Capital Expenditures over the past three periods registered $11.1 million, $19.8 million, and $20.2 million for Q3 2026, Q2 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 450.00 Mn |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | 269.00 Mn |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | 80.00 Mn |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | 40.00 Mn |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | 11.07 Mn |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | 8.48 Mn |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | 32.00 Mn |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | 5.33 Mn |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | 1.59 Mn |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | 28.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 5, 2026 | 11.07 Mn |
| Apr 5, 2026 | 19.78 Mn |
| Dec 28, 2025 | 20.17 Mn |
| Sep 28, 2025 | 18.50 Mn |
| Jun 29, 2025 | 18.87 Mn |
| Mar 30, 2025 | 15.98 Mn |
| Dec 29, 2024 | 24.45 Mn |
| Sep 29, 2024 | 22.32 Mn |
| Jun 30, 2024 | 22.03 Mn |
| Mar 31, 2024 | 17.84 Mn |
| Dec 31, 2023 | 24.12 Mn |
| Oct 1, 2023 | 22.36 Mn |
| Jul 2, 2023 | 13.95 Mn |
| Apr 2, 2023 | 20.95 Mn |
| Jan 1, 2023 | 26.57 Mn |
| Apr 3, 2022 | 26.97 Mn |
| Oct 3, 2021 | 24.39 Mn |
| Jul 4, 2021 | 20.36 Mn |
| Apr 4, 2021 | 14.31 Mn |
| Jan 3, 2021 | 6.24 Mn |